Physician: AI rare-disease reports must separate proven therapies and keep an evidence audit trail
zakkohane · x · 2026-11-04
Responding to an AI project for rare-disease diagnosis, DrSurenMD notes diagnostic delay — years of referrals and fragmented records — is where families feel the gap most. He argues actionable AI reports must clearly separate established therapies from plausible-but-unproven options with cited evidence, be easy for clinicians to update when variant classifications or trial results change, and maintain an audit trail to be trusted in clinic.
More from AGI Musings
- State of AI author Nathan Benaich on recursive self-improvement and why AI-native firms grow 3x faster — arena · 2026-11-05
- Luiza Jarovsky: AI labs are co-responsible for rising AI cyberattacks and should be legally required to help defend society — LuizaJarovsky · 2026-11-05
- CellType claims 27B biology model beats all 12 frontier models at predicting cell behavior — alifcoder · 2026-11-05
- AI circle debates Dario's 'Machines of Loving Grace' and EA-shaped Claude — teortaxesTex · 2026-11-05
- Inside a16z's agent podcast: trust is the top fear among 147 tracked AI assistants — a16z · 2026-11-05
- Who gets to be expensive? Agents get subsidized while companion users get rationed — serialchilla91 · 2026-11-05